Integration of the clinical laboratory in cardiovascular medicine

Reviews in Cardiovascular Medicine

Volumn 11, Issue SUPPL. 2, 2010, Pages

  McCullough, Peter A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Acute coronary syndrome; Acute myocardial infarction; B type natriuretic peptide; Clinical laboratory; Diagnosis; Management; N terminal prohormone; Prognosis; Screening

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; HORMONE PRECURSOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; NATRIURETIC FACTOR;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; CARDIOLOGY; CARDIOVASCULAR MEDICINE; CARDIOVASCULAR RISK; CELL DEATH; CLINICAL LABORATORY; CLINICAL PRACTICE; CORONARY ARTERY ATHEROSCLEROSIS; ELECTROCARDIOGRAM; HEALTH CARE UTILIZATION; HEART FAILURE; HOSPITALIZATION; HUMAN; INTEGRATION; INTERNAL MEDICINE; ISCHEMIC HEART DISEASE; LABORATORY TEST; LUNG EMBOLISM; MORTALITY; NONHUMAN; OCCULT BLOOD TEST; PATIENT CARE; PROGNOSIS; SCREENING; SHORT SURVEY; STROKE; ALGORITHM; ANIMAL; BLOOD; CARDIOVASCULAR DISEASE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DIAGNOSTIC TEST; INTEGRATED HEALTH CARE SYSTEM; ORGANIZATION AND MANAGEMENT; PREDICTION AND FORECASTING; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ACUTE CORONARY SYNDROME; ALGORITHMS; ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CLINICAL LABORATORY TECHNIQUES; DELIVERY OF HEALTH CARE, INTEGRATED; DIAGNOSTIC TESTS, ROUTINE; HUMANS; NATRIURETIC PEPTIDES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 77958120147     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: 10.3909/ricm11S2S0007     Document Type: Short Survey

References (13)

1. Forssmann WG, Nokihara K, Gagelmann M, et al. The heart is the center of a new endocrine, paracrine, and neuroendocrine system. Arch Histol Cytol. 1989;S2(suppl):293-315.
2. Ewald B, Ewald D, Thakkinstian A, Attia J. Metaanalysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction. Intern Med J. 2008;38:101-113. (Pubitemid 351257947)
3. Clerico A, Fontana M, Zyw L, et al. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP Immunoassays in chronic and acute heart failure: a systematic review. Clin Chem. 2007;53:813-822. (Pubitemid 46744235)
4. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006;27:330-337. (Pubitemid 43100029)
5. Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am ] Resplr Crit Care Med. 2008;178:425-430.
6. Rodseth RN, Padayachee L, Biccard BM. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia. 2008;63:1226-1233.
7. Ryding AD, Kumar S, Worthington AM, Burgess D. Prognostic value of brain natriuretic peptide In non-cardiac surgery: a meta-analysis. Anesthesiology. 2009;111:311-319.
8. McCullough PA, Kuncheria J, Mathur VS. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal Insufficiency and decompensated heart failure. Rev Cardiovasc Med. 2004;5:16-25. (Pubitemid 38344496)
9. Safley DM, Awad A, Sullivan RA, et al. Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function. Adv Chronic Kidney Dis. 2005;12:117-124. (Pubitemid 40255613)
10. Felker GM, Hasselblad V, Hernandez AF, O'Connor CM. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J. 2009;158:422-430.
11. Vanhecke TE, Franklin BA, Maciejko J, et al. Lipoproteins, inflammatory biomarkers, and cardiovascular imaging in the assessment of atherosclerotic disease activity. Rev Cardiovasc Med. 2009,10:51-58.
12. Anderson JL, Adams CD, Antman EM, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50:e1-e157.
13. Kushner FG, Hand M, Smith SC Jr, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120:2271-2306.